Laparoscopic Radical Hysterectomy with Pelvic Lymphadenectomy in Early Invasive Cervical Cancer

Sabina Salicrú, Antonio Gil-Moreno, Anabel Montero, Marisa Roure, Assumpció Pérez-Benavente, Jordi Xercavins

Research output: Contribution to journalReview articleResearchpeer-review

29 Citations (Scopus)


Laparoscopic radical hysterectomy is one surgical procedure currently performed to treat gynecologic cancer. The objective of this review was to update the current knowledge of laparoscopic radical hysterectomy in early invasive cervical cancer. Articles indexed in the MEDLINE database using the key words "Laparoscopic radical hysterectomy" and "Cancer of the cervix" were reviewed. Studies of laparoscopic radical hysterectomy for treatment of early cervical cancer with a minimum study population of 10 patients were selected. The laparoscopic approach was associated with less surgical morbidity (surgical bleeding) and with shorter length of hospital stay, although the duration of the operation may be longer. Laparoscopic radical hysterectomy with endoscopic pelvic lymphadenectomy, and paraaortic lymphadenectomy if needed, is a safe surgical option for treatment and staging of early invasive cervical cancer considering surgical risk, intraoperative bleeding, intraoperative and postoperative complications, and patient recovery. It is important to respect the learning curve. Surgical advances including new laparoscopic instrumentation and, in particular, use of robotics will contribute to reducing the duration of the operation and to facilitating learning and teaching of the procedure. © 2011 AAGL.
Original languageEnglish
Pages (from-to)555-568
JournalJournal of Minimally Invasive Gynecology
Issue number5
Publication statusPublished - 1 Sept 2011


  • Cervical cancer
  • Laparoscopic radical hysterectomy
  • Laparoscopic surgery
  • Pelvic lymphadenectomy
  • Robotic surgery
  • Surgical morbidity


Dive into the research topics of 'Laparoscopic Radical Hysterectomy with Pelvic Lymphadenectomy in Early Invasive Cervical Cancer'. Together they form a unique fingerprint.

Cite this